# Long-term Beta-blocker Therapy After Acute Myocardial Infarction

> **NCT04769362** · PHASE4 · RECRUITING · sponsor: **Samsung Medical Center** · enrollment: 2540 (estimated)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** Discontinuation of β-blocker

## Key facts

- **NCT ID:** NCT04769362
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-05-04
- **Primary completion:** 2026-01-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 2540 (ESTIMATED)
- **Last updated:** 2025-12-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04769362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04769362, "Long-term Beta-blocker Therapy After Acute Myocardial Infarction". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04769362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*